CORDIS · 260895 · FP7
PREDICTA Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases
Coordinator: ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (EL)
Chronic inflammatory diseases associated with allergy, including asthma and rhinitis, constitute a major and continuously growing public health concern for Europe. However, the causative factors and mechanisms converting a physiological inflammatory reaction to a chronic response triggering allergic disease remain elusive.Viral infections, particularly those caused by human rhinoviruses (RV) are the most frequent triggers of acute asthma exacerbations. RV infections have more recently been associated with asthma initiation; there is evidence suggesting that such infections may also contribute…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €6.0M awarded to the consortium. The project runs over approximately 5.5 years from 2010-10-01 to 2016-03-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from EL
see all →- Theseus — A First of a kind Hub for circularity demonstrator for Attica and peripheral regions101178059 · HORIZON · €20.0M
- COMFORTAGE — Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty101137301 · HORIZON · €17.6M
- Flex2Energy — Automated Manufacturing Production Line for Integrated Printed Organic Photovoltaics101096803 · HORIZON · €15.7M
- HERON — HERON Center of Excellence in Robotics101136568 · HORIZON · €15.0M
- SEAMLESS — Safe, Efficient and Autonomous: Multimodal Library of European Shortsea and inland Solutions101096923 · HORIZON · €15.0M
- FIDAL — Field Trials beyond 5G101096146 · HORIZON · €15.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-FP funding scheme.
- What is the EU contribution?
- The European Commission contributes €6.0M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (EL).
- What is the project timeline?
- The project runs from 2010-10-01 to 2016-03-31 — approximately 5.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 260895.